Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Jeetayu Biswas
splicing in myeloid diseases
Jolanta Grembecka
leukemia therapeutics
Armin Rashidi
gut bacteria and transplant success
Tycel Phillips
Mantle Cell Lymphoma
Huda Salman
CMML
Qing Yi
Novel CAR-T
John Crispino
myelofibrosis, pediatric leukemia and Downs
Dimericon Therapeutics
dimericons, blood cancer
Dane Vassiliadis
blood cancer biology
Leandro Cerchietti
DLBCL
Solu Therapeutics
immunotherapy, CMML
Ann-Kathrin Eisfeld
Racial diversity in AML
Piers Patten
COVID-19
Eric Pietras
AML
Manyi Wei
acute megakaryoblastic leukemia
Marc Seifert
Hairy cell leukemia
John Leonard
lymphoma research
Lev Kats
myeloma and epigenetics
Randall Davis
CLL
Peter Croucher
Multiple Myeloma
Nicolas Nassar
pediatric leukemia
Sarah Tasian
pediatric leukemias
Venkata Lokesh Battula
immunotherapy and AML
Daniel Thomas
Myelofibrosis
Madhav Dhodapkar
multiple myeloma immunotherapy
Lori Muffly
Equity in Access
Alieen Rowan
Adult T cell leukemia/lymphoma
Rajni Kumari
AML
Ari Melnick
epigenetics and lymphoma
Frederick Locke
lymphoma and immunotherapy
Amin Sobh
Myeloma biology
Michael Green
lymphoma biology
Arash Alizadeh
blood cancer biology and diagnosis
Tanya Siddiqi
clinical trial access
Jun Qi
Myeloma
Peter Klein
MDS
Courtney Jones
AML metabolism
Stephen Nimer
myeloid cancer biology
Amit Verma
AML/MDS
Adam Olszewski
Follicular and marginal zone lymphoma
Thomas LeBlanc
palliative care
Hao Jiang
DNA biology and leukemia
Yoke Seng Lee
AML
Lucy Godley
preleukemia
Catherine Bollard
pediatric blood cancers and immunotherapy
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Julia Maxson
AML
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Ryan Wilcox
T-cell lymphoma
Yiman Liu
Epigenetics and leukemia
Megan McNerney
AML/MDS
Christopher Porter
Leukemia, lymphoma
Siegfried Janz
Myeloma immunotherapy
Koichi Takahashi
AML/MDS
Inhye Ahn
CLL
Michael Keller
COVID-19, immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Maximilian Stahl
AML immunotherapy
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Michael Kharas
leukemia
Frederike Kramer
MPNs
Lakshmi Nayak
brain tumors in lymphoma
Michael Savona
MDS and leukemia
Yubin Zhou
peripheral T cell lymphoma
Marina Konopleva
MDS/AML metabolism
Kirk Schultz
pediatric transplantation
Nitin Jain
CLL
Steven Park
follicular lymphoma
Sam Butterworth
CMML
F. Lennie Wong
Equity in Access
Jean Koff
Disparities in DLBCL
Stephen Oh
myeloproliferative neoplasms
Grant Challen
preleukemia, leukemia
Margaret Shipp
lymphoma biology
Cailin Collins
Leukemia and pre-leukemia
James Rubenstein
Lymphoma of the Central Nervous System
Richard Lock
T-ALL
Daniel Lucas
bone marrow and leukemia biology
Noemí Puig Morón
Myeloma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Mala Shanmugam
myeloma
Brian Dalton
DNA mutations and myeloid cancers
Jonas Jutzi
myeloproliferative neoplasms
Caner Saygin
T-ALL
Bingyi Chen
AML immunotherapy
Steven Horwitz
T-cell lymphomas
Carl Allen
pediatric blood cancers
Yibin Yang
Lymphoma
Steven Treon
Lymphomas and Waldenstrom's
Caron Jacobson
lymphoma and immunotherapy
Kathleen Sakamoto
pediatric AML
Coleman Lindsley
AML/MDS
Helen Parsons
Equity in Access
Julia Paczkowska
immunobiology of Hodgkin's disease
Caroline Arber
myeloma CAR-T
Simona Colla
Myeloma biology
Daniel Herranz
T-ALL
Neha Mehta-Shah
T-cell lymphoma
Gaurav Goyal
Erdheim-Chester Disease
Justine Kahn
pediatric leukemia and lymphoma
Sergei Doulatov
Leukemias
Kimberly Stegmaier
childhood blood cancers
Sahand Hormoz
MPN
Jennifer Woyach
CLL trials
Tak Mak
Immunotherapy
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Sigurður Kristinsson
Smoldering myeloma
Gareth Morgan
smoldering myeloma, MGUS
Matthew Frank
Lymphoma CART therapy
Areej El-Jawahri
transplant survivorship
Bailee Kain
AML and African ancestry
Saar Gill
AML immunotherapy
Jaehyuk Choi
T-cell lymphoma
Nicola Vannini
Aging and CAR-T success
Constellation Pharmaceuticals
myeloproliferative neoplasms
Affimed
immunotherapy, HL, PTCL
Eugenio Morelli
Myeloma
Kerry Rogers
CLL
Adam de Smith
pediatric ALL and Down Syndrome
Philippe Armand
follicular lymphoma
Robert Orlowski
(Smoldering) Multiple Myeloma
Nirav Shah
CAR-T for lymphoma
Jianguo Tao
Mantle Cell Lymphoma
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Kura Oncology
MLL leukemia, AML
Thomas Koehnke
leukemia
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Markus Muschen
leukemia and lymphoma biology
Jessica Stewart
Epstein-barr virus and lymphomas
Jaroslaw Maciejewski
bone marrow failure
Xu Ji
Equity in Access
Thomas Kipps
Hairy Cell Leukemia
Alex Kentsis
pediatric leukemias
Anushree Vichare
Equity in Access
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Matteo Bellone
Smoldering multiple myeloma
Elliot Stieglitz
CMML
Ravi Bhatia
transplantation
Jennifer Trowbridge
aging and leukemia
Rgenta Therapeutics
RNA-targeting, blood cancer
Joachim Yahalom
Lymphoma
Ricky Johnstone
lymphoma and myeloma
Raymond Mailhot
Equity in Access
Takeshi Sugio
T-cell lymphoma
Roberta Zappasodi
lymphoma, immunotherapy
Riccardo Dalla-Favera
lymphoma (DLBCL)
Carma Bylund
Equity in Access
Kasey Leger
pediatric blood cancers
John DiPersio
trispecific antibody for AML and MDS
Nizar Bahlis
Myeloma immunotherapy
Andrew Lane
BPDCN
Paolo Strati
Non-Hodgkin Lymphoma
Sham Mailankody
Myeloma immunotherapy clinical trials
Alison Moskowitz
lymphoma therapeutics
Omar Abdel-Wahab
Hairy cell leukemia
Mark Murakami
follicular lymphoma
Alfred Garfall
myeloma immunotherapy
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Sriram Sundaravel
AML stem cells
Liran Shlush
pre-leukemia
Rizwan Romee
Immunotherapy
Nataly Cruz-Rodriguez
T-ALL and metabolism
Christian Steidl
B-cell lymphomas
Eric Padron
CMML
Jalpa Doshi
Equity in Access
Bing Carter
p53 mutant AML
Sisi Chen
leukemia
Mark Hamilton
DLBCL and CAR-T
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Martin Dreyling
Mantle Cell Lymphoma
Trent Hall
MDS
Jing Yang
Myeloma
Hong Wen
AML
Catherine Smith
leukemia
Alec Zhang
myeloma, immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Suzanne Lentzsch
Myeloma
Christopher Booth
BPDCN
Anouchka Laurent
T-cell lymphoma
Robert Soiffer
transplantation
Grzegorz Nowakowski
Clinical trial access
Reina Takeda
AML
Christopher Flowers
clinical trial access
Sheng Li
Aging and AML
Jeremy Baeten
AML
Mendel Goldfinger
MDS/AML trials for the elderly
Christian Marinaccio
MLL leukemias
Timothy Graubert
AML and MDS biology
Brian Walker
smoldering myeloma, MGUS
Catherine Diefenbach
DLBCL immunology
Jake Shortt
precision therapy for aggressive lymphomas
Christine Zhang
AML
Suman Paul
T cell cancers and immunotherapy
Rachel Mersfelder
AMKL
Tomasz Skorski
myeloproliferative neoplasms, AML
Lawrence Boise
CART and myeloma
Stacie Dusetzina
Equity in Access
Srividya Swaminathan
pediatric, immunotherapy
William Matsui
Myeloma
Taishi Yonezawa
AML
Daniel Pollyea
AML
Urvi Shah
Diet and myeloma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Tyler Parsons
MPN and AML
Dan Landau
cancer evolution biology
Nicoletta Cieri
AML and transplantation
Teresa Palomero
Peripheral T-cell Lymphoma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Jing Fu
myeloma
Lindsey Montefiori
pediatric leukemia
Enterome
vaccine, FL, MZL
Eirini Papapetrou
blood cancer stem cells
Adi Nagler
Bronchiolitis obliterans after transplant
Qingyu Luo
BPDCN
Michael Wang
Mantle Cell Lymphoma
Alexey Danilov
lymphoma
Fahmin Basher
transplant and GvHD
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Jonathan Licht
DNA biology, myeloma
Britta Will
Leukemia and pre-leukemia
Faron Pharmaceuticals
immunotherapy, MDS
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Yan Liu
MDS
Fenghuang Zhan
Myeloma and bone disease
Wendy Stock
T-cell ALL
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Catriona Jamieson
cancer stem cell biology
Roland Walter
Antibody-based AML therapies
Carl June
CAR T immunotherapy
Rong Lu
preleukemia, leukemia
Shannon Maude
Immunotherapy for ALL
Siddhartha Jaiswal
preleukemia
Paolo Caimi
CAR-T clinical trial for CLL
Paul Beavis
immunotherapy in myeloma
Ravindra Majeti
preleukemia, AML
Oreofe Odejide
Equity in Access
Stephen Gottschalk
pediatric leukemia and CAR-T
H. Irene Su
Equity in Access
Daisuke Nakada
preleukemia, leukemia
Jianhua Yu
myeloma immunotherapy
Ana Vujovic
AML
Gianpietro Dotti
CAR T and AML
Mark Dawson
B-ALL and CAR-T resistance
Anthony Letai
improving CAR-T
Jayna Mistry
aging and leukemias
Jeffrey Magee
pediatric AML
Keisuke Ito
blood cancer stem cells and MDS metabolism
ImCheck Therapeutics
immunotherapy, AML
Luca Busino
DLBCL
Jenny Wang
AML
BioInvent International
immunotherapy, indolent NHL, CTCL
Shazia Nakhoda
Equity in Access
Liling Wan
AML
Enrico Tiacci
Hairy cell leukemia
Pooja Khandelwal
bone marrow transplantation
Craig Jordan
AML
Pietro Genovese
transplant and AML
Meng Li
Equity in Access
Wendy Béguelin
follicular lymphoma
Ruben Carrasco
Myeloma
Logan Spector
childhood leukemia epidimiology
Michaela Reagan
Multiple Myeloma
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Daniel Starczynowski
MDS and AML
Marco Ruella
Immunotherapy for T-cell lymphoma
Bruno Paiva
smoldering myeloma
Susan Schwab
cancer immunology
Ronald Levy
immunotherapies, COVID-19
Soheil Meshinchi
pediatric AML
Courtney DiNardo
clinical trials, AML
George Vassiliou
Leukemia Prevention